Annual Non Current Assets
$76.80 M
+$37.32 M+94.51%
September 30, 2024
Summary
- As of February 8, 2025, ENTA annual long term assets is $76.80 million, with the most recent change of +$37.32 million (+94.51%) on September 30, 2024.
- During the last 3 years, ENTA annual non current assets has fallen by -$42.97 million (-35.88%).
- ENTA annual non current assets is now -35.88% below its all-time high of $119.77 million, reached on September 30, 2021.
Performance
ENTA Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$76.80 M
-$35.44 M-31.57%
September 30, 2024
Summary
- As of February 8, 2025, ENTA quarterly long term assets is $76.80 million, with the most recent change of -$35.44 million (-31.57%) on September 30, 2024.
- Over the past year, ENTA quarterly non current assets has increased by +$37.32 million (+94.51%).
- ENTA quarterly non current assets is now -40.59% below its all-time high of $129.28 million, reached on June 30, 2021.
Performance
ENTA Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
ENTA Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +94.5% | +94.5% |
| 3 y3 years | -35.9% | -35.9% |
| 5 y5 years | -12.7% | -35.9% |
ENTA Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -35.9% | +94.5% | -32.4% | +101.1% |
| 5 y | 5-year | -35.9% | +94.5% | -40.6% | +119.0% |
| alltime | all time | -35.9% | +7603.1% | -40.6% | +7603.1% |
Enanta Pharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $299.85 M(-29.1%) | $76.80 M(-31.6%) |
| Jun 2024 | - | $112.24 M(+79.5%) |
| Mar 2024 | - | $62.53 M(+63.7%) |
| Dec 2023 | - | $38.20 M(-3.3%) |
| Sep 2023 | $422.79 M(+35.6%) | $39.48 M(-15.5%) |
| Jun 2023 | - | $46.70 M(-15.6%) |
| Mar 2023 | - | $55.31 M(-13.4%) |
| Dec 2022 | - | $63.83 M(+0.2%) |
| Sep 2022 | $311.71 M(-2.3%) | $63.70 M(-11.8%) |
| Jun 2022 | - | $72.18 M(+11.1%) |
| Mar 2022 | - | $64.95 M(-42.8%) |
| Dec 2021 | - | $113.64 M(-5.1%) |
| Sep 2021 | $319.02 M(-27.0%) | $119.77 M(-7.4%) |
| Jun 2021 | - | $129.28 M(+226.9%) |
| Mar 2021 | - | $39.55 M(+12.8%) |
| Dec 2020 | - | $35.07 M(-28.9%) |
| Sep 2020 | $436.84 M(+8.7%) | $49.30 M(-49.9%) |
| Jun 2020 | - | $98.32 M(-11.3%) |
| Mar 2020 | - | $110.79 M(+57.2%) |
| Dec 2019 | - | $70.47 M(-19.9%) |
| Sep 2019 | $401.85 M(+5.6%) | $87.98 M(+295.9%) |
| Jun 2019 | - | $22.22 M(-41.1%) |
| Mar 2019 | - | $37.74 M(+22.1%) |
| Dec 2018 | - | $30.91 M(-8.7%) |
| Sep 2018 | $380.39 M | $33.84 M(-13.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $39.19 M(-20.0%) |
| Mar 2018 | - | $48.98 M(-47.4%) |
| Dec 2017 | - | $93.09 M(+4.8%) |
| Sep 2017 | $237.82 M(+2.4%) | $88.82 M(+27.4%) |
| Jun 2017 | - | $69.72 M(-21.1%) |
| Mar 2017 | - | $88.37 M(+62.7%) |
| Dec 2016 | - | $54.31 M(+10.6%) |
| Sep 2016 | $232.16 M(+36.0%) | $49.12 M(+22.4%) |
| Jun 2016 | - | $40.14 M(+3.1%) |
| Mar 2016 | - | $38.93 M(-43.9%) |
| Dec 2015 | - | $69.36 M(-8.0%) |
| Sep 2015 | $170.64 M(+58.0%) | $75.37 M(+15.7%) |
| Jun 2015 | - | $65.13 M(-4.4%) |
| Mar 2015 | - | $68.10 M(+124.5%) |
| Dec 2014 | - | $30.33 M(-36.1%) |
| Sep 2014 | $107.97 M(+3.1%) | $47.44 M(-0.8%) |
| Jun 2014 | - | $47.84 M(+431.7%) |
| Mar 2014 | - | $9.00 M(-43.0%) |
| Dec 2013 | - | $15.78 M(+28.7%) |
| Sep 2013 | $104.71 M(+121.3%) | $12.26 M(-43.8%) |
| Jun 2013 | - | $21.80 M(+56.2%) |
| Mar 2013 | - | $13.96 M(+21.1%) |
| Dec 2012 | - | $11.53 M(+137.6%) |
| Sep 2012 | $47.31 M(+88.5%) | $4.85 M(+36.9%) |
| Jun 2012 | - | $3.54 M(+255.6%) |
| Sep 2011 | $25.10 M | $997.00 K |
FAQ
- What is Enanta Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals annual non current assets year-on-year change?
- What is Enanta Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals quarterly non current assets year-on-year change?
What is Enanta Pharmaceuticals annual long term assets?
The current annual non current assets of ENTA is $76.80 M
What is the all time high annual non current assets for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high annual long term assets is $119.77 M
What is Enanta Pharmaceuticals annual non current assets year-on-year change?
Over the past year, ENTA annual long term assets has changed by +$37.32 M (+94.51%)
What is Enanta Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of ENTA is $76.80 M
What is the all time high quarterly non current assets for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high quarterly long term assets is $129.28 M
What is Enanta Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, ENTA quarterly long term assets has changed by +$37.32 M (+94.51%)